Xcout Intel
Precede Biosciences
Precede Biosciences is a biotechnology company developing blood-based liquid-biopsy technologies for molecular profiling of cancer. Its tests are intended to support oncology research, precision treatment decisions, and pharmaceutical drug-development programs.
Subscribe to see Precede Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Precede Biosciences at a glance
Precede Biosciences is a biotech company. Xcout tracks 11 named people at Precede Biosciences, including Jennifer Fortune, PhD (Chief Operating Officer). Xcout recorded 4 job postings from Precede Biosciences in the last 90 days.
Precede Biosciences leadership
- Jennifer Fortune, PhDChief Operating Officer
- Humphrey Gardner, MDActing Chief Medical Officer
- J. Carl BarrettChief Scientific Advisor
- Michaela Bowden, PhDChief Scientific Officer
- Jessica Alfano, Esq.Vice President, Head of Legal
- Josephine N. Harada, MBA, PhDVice President, Corporate and Business Development
5 more named people on record for Precede Biosciences, with roles, board committees and tenure — see the full roster →
Hiring at Precede Biosciences
Xcout recorded 4 job postings from Precede Biosciences in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Precede Biosciences's hiring signals →
Precede Biosciences competitors
A few of Precede Biosciences's closest competitors — see the full list of competitors and alternatives →
Predicine Holdings Ltd provides next-generation liquid biopsy platforms and molecular profiling services for cancer research and precision medicine. The company utilizes proprietary blood- and urine-based assays to analyze circulating tumor DNA and RNA, serving biopharmaceutical partners and clinical researchers in oncology drug development and clinical trials.
Predicta Biosciences is a precision oncology company that builds a molecular insights platform for blood cancer care. By utilizing a single blood sample, the company integrates multiomics and liquid biopsies to generate longitudinal genomic and immune insights for diagnostics.
Resolution Bioscience is a precision medicine company specializing in cancer diagnostics, DNA sequencing, and liquid biopsy, located in Bellevue, Washington.
Lucence is a precision oncology and health diagnostics company that provides ultrasensitive liquid biopsy tests, including cancer screening, treatment selection, and health risk assessment solutions. Using proprietary technologies like AmpliMARK, the company analyzes blood-based genetic material to detect cancer mutations, early-stage malignancies, and cardiovascular risks for patients and healthcare providers.
Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company's proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome's first commercial-stage test, SimpleScreen CRC for colorectal cancer, is under review by the U.S. Food and Drug Administration (FDA).
Capio Biosciences is an oncology diagnostics company that develops advanced technologies for capturing and analyzing circulating tumor cells (CTCs) from whole blood. Its proprietary CapioCyte platform offers enhanced sensitivity compared to traditional methods, serving as a research tool designed to help oncologists make informed cancer treatment decisions.
Get Precede Biosciences's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Precede Biosciences in Xcout Intel
- 11 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access